ArticleOphthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)2026
Contrast Sensitivity Function in Parkinson's Disease: Effects of Illumination and Disease Stage.
Article in Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eye-Tracking Assessment of Visual, Oculomotor, and Pupillary Biomarkers During Reading in Parkinson's Disease.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeContrast sensitivity function (CSF) is a valuable tool for assessing visual function, which can be affected in neurodegenerative disorders such as Parkinson's Disease (PD). Visual perception in everyday life depends on the ability to detect objects across a wide range of spatial frequencies under different illumination conditions. However, the effect of disease progression and varying illumination on CSF in individuals with PD remains underexplored. The aim of this study was to investigate CSF in PD participants across six illumination conditions, examining disease stage influence and comparing results with age-matched healthy controls.
methodsCSF was measured with the Functional Acuity Contrast Test. This prospective, comparative study evaluated CSF under photopic, mesopic and glare conditions, across disease stages, classified according to the Hoehn and Yahr Scale. The index of contrast sensitivity (ICS) assessed overall CSF.
resultsSeventy-one PD participants and 97 healthy controls were included. PD participants demonstrated significantly poorer CSF than controls across photopic, mesopic and glare conditions (mixed-model analysis, p < 0.001). The most pronounced impairment was observed under mesopic conditions with mild glare (ICS: 33 vs. 2.5, p = 0.02). Unadjusted analyses suggested a decline in CSF with advancing disease stage; however, this effect was attenuated after controlling for age. No significant relationship was found between disease progression and ICS after age adjustment under any illumination condition.
conclusionsThis is the first study to assess CSF comprehensively with ICS data under six illumination conditions in PD, considering disease stage and comparing with controls. PD participants experience significant visual deficits, particularly under mesopic and glare conditions. While contrast impairments are robust in PD, stage-related differences appear partially influenced by age. These findings highlight the clinical importance of evaluating CSF under ecologically relevant lighting environments to better characterise functional visual impairment in PD and its impact on activities of daily living.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.